Recent News

• 09.04.2026 - Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
• 09.04.2026 - Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
• 07.13.2026 - Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Technology and Lead Product Candidate MAT2203 to Azurity Pharmaceuticals
• 07.13.2026 - Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Technology and Lead Product Candidate MAT2203 to Azurity Pharmaceuticals
• 06.26.2026 - Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance
• 06.26.2026 - Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance
• 04.03.2026 - Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
• 04.03.2026 - Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
• 03.31.2026 - 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
• 04.29.2025 - ARS - Annual Report to Security Holders

Recent Filings

• 09.04.2026 - 8-K Current report
• 09.04.2026 - EX-99.1 EX-99.1
• 08.25.2026 - 425 Prospectuses and communications, business combinations
• 08.13.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.13.2026 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 08.13.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.13.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.04.2026 - 425 Prospectuses and communications, business combinations
• 07.30.2026 - 425 Prospectuses and communications, business combinations
• 07.29.2026 - 425 Prospectuses and communications, business combinations